Use of [18F]fluorocholine PET/CT in the detection of primary hyperparathyroidism in paediatrics: a case report

被引:0
|
作者
Sanchez, Helena Martinez [1 ]
Macian, Francisca Moreno [2 ]
Carinena, Sara Leon [2 ]
Alemany, Carmen de Mingo [3 ]
Gonzalez, Lidia Blasco [4 ]
Vano, Raquel Sanchez [5 ]
机构
[1] Hosp La Fe, Dept Pediat, Fernando Abril Martorell Ave 106, Valencia 46026, Spain
[2] Hosp Univ & Politecn La Fe, Valencia, Spain
[3] Univ & Polytech Hosp La Fe, Dept Pediat Endocrinol, Valencia, Spain
[4] Sagunto Hosp, Sagunto, Spain
[5] La Fe Univ & Polytech Hosp, Dept Nucl Med, Valencia, Valemcia, Spain
来源
关键词
hyperparathyroidism; parathyroid adenoma; F-18-fluorocholine PET/CT;
D O I
10.1515/jpem-2023-0556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The most common cause of primary hyperparathyroidism (PPH) in children is a parathyroid adenoma. Among this population, PPH exhibits higher levels of morbidity, severity and target organ involvement compared to adults. When there is suspicion of PPH, cervical ultrasound and Tc-99m-sestamibi SPECT/CT are the imaging test traditionally indicated. Among adults, the use of [F-18]fluorocholine PET/CT has shown a higher sensitivity than ultrasound and [Tc-99m]sestamibi SPECT/CT, leading to an expanding adoption in recent years. However, its role in paediatrics has not been clearly defined yet. Case presentation: The patient is an adolescent female aged 13 years presented with lithiasis. The analytical study revealed elevated PTH, hipovitaminosis D, hypercalcaemia and hypophosphataemia. Due to the suspicion of PPH, cervical ultrasound and Tc-99m-sestamibi SPECT/C were performed, failing to identify hyperfunctioning parathyroid glands. We proceeded to carry out a [F-18]fluorocholine PET/CT where a hypermetabolic nodular image was identified, compatible with a hyperfunctioning parathyroid adenoma. The patient underwent surgery, resulting in the normalisation of PTH levels. Pathological anatomy confirmed the presence of a parathyroid adenoma. Conclusions: In cases where conventional imaging tests yield negative results or discrepancies, we suggest the possibility of the use of [F-18]fluorocholine PET/CT for the detection of hyperfunctioning parathyroid adenomas.
引用
下载
收藏
页码:580 / 584
页数:5
相关论文
共 50 条
  • [1] [18F]Fluorocholine PET/CT in pediatric primary hyperparathyroidism
    Treglia, Giorgio
    Zanetti, Benedetto
    Simonetti, Giacomo D.
    PEDIATRIC RADIOLOGY, 2024, : 2094 - 2095
  • [2] Preoperative Imaging with [18F]-Fluorocholine PET/CT in Primary Hyperparathyroidism
    Dekorsy, Franziska J.
    Beyer, Leonie
    Spitzweg, Christine
    Schmidmaier, Ralf
    Todica, Andrei
    Trupka, Arnold
    Cyran, Clemens C.
    Berger, Frank
    Ladurner, Roland
    Zimmermann, Petra
    Knoesel, Thomas
    Bartenstein, Peter
    Lottspeich, Christian
    Wenter, Vera
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [3] [18F]-Fluorocholine PET/CT in primary hyperparathyroidism: Initial experience
    Fernandez Fernandez, J.
    Muros de Fuentes, M.
    Trivino Ibanez, E.
    de la Torre Casares, M. Lopez
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S566 - S566
  • [4] Lincoln Sign in a Case of Primary Hyperparathyroidism on 18F-Fluorocholine PET/CT
    Prakash, Sneha
    Damle, Nishikant Avinash
    Kumar, Praveen
    Dharmashaktu, Yamini
    Bal, C. S.
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (07) : E343 - E344
  • [5] Diagnostic performance of (18F)-Fluorocholine PET/CT in comparison to conventional scintigraphic imaging in primary hyperparathyroidism
    Cuderman, A.
    Rep, S.
    Hocevar, M.
    Zaletel, K.
    Sever, M. Jensterle
    Kocjan, T.
    Lezaic, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S244 - S245
  • [6] Expanding the clinical indications of [18F]fluorocholine PET/CT in primary hyperparathyroidism: the evidence cannot be evaded
    Treglia, Giorgio
    Rizzo, Alessio
    Piccardo, Arnoldo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (05) : 1345 - 1348
  • [7] Expanding the clinical indications of [18F]fluorocholine PET/CT in primary hyperparathyroidism: the evidence cannot be evaded
    Giorgio Treglia
    Alessio Rizzo
    Arnoldo Piccardo
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1345 - 1348
  • [8] 18F-fluorocholine PET/CT and conventional imaging in primary hyperparathyroidism
    Dudoignon, David
    Delbot, Thierry
    Cottereau, Anne Segolene
    Dechmi, Amina
    Bienvenu, Marie
    Koumakis, Eugenie
    Cormier, Catherine
    Gaujoux, Sebastien
    Groussin, Lionel
    Cochand-Priollet, Beatrix
    Clerc, Jerome
    Wartski, Myriam
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2022, 103 (05) : 258 - 265
  • [9] 18F-Fluorocholine PET/CT in persistent/recurrent primary hyperparathyroidism
    Naik, M.
    Khan, S. R.
    Patel, N. H.
    Perry, L.
    Alsafi, A.
    Harvey, C.
    Alves, L.
    Palazzo, F.
    Barwick, T. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S420 - S420
  • [10] Added value of [18F]fluorocholine PET/CT in the evaluation of secondary or tertiary hyperparathyroidism
    Abouzian, S.
    Lopez-Mora, D. A.
    Fernandez-Leon, A.
    Facundo, C.
    Stefaneli, P.
    Flotats, A.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2024, 43 (03):